A summary overview of the new, direct, target-specific oral anticoagulants
In the past 10 years or so, many alternatives to warfarin have been developed the first being the novel oral anticoagulants (NOAC) or better referred to as direct oral anticoagulants (DOAC) or target-specific oral anticoagulants (TSOAC). These drugs have some definite advantages and disadvantages th...
Guardado en:
Autor principal: | G. L. Muntingh |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
AOSIS
2016
|
Materias: | |
Acceso en línea: | https://doaj.org/article/bc46706e7b02461ebd810a723ca70cc8 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Direct oral anticoagulants; a review for the non-specialist
por: Thilina Gunawardena
Publicado: (2021) -
Persistence of oral anticoagulant treatment for atrial fibrillation in the Netherlands: A surveillance study
por: Gilda Denise Zielinski, et al.
Publicado: (2020) -
Stroke prevention in the elderly atrial fibrillation patient with comorbid conditions: focus on non-vitamin K antagonist oral anticoagulants
por: Turagam MK, et al.
Publicado: (2015) -
Direct Oral Anticoagulants versus Warfarin in Octogenarians with Nonvalvular Atrial Fibrillation: A Systematic Review and Meta-Analysis
por: Clara Bonanad, et al.
Publicado: (2021) -
Severe gastrointestinal bleeding in patients with atrial fibrillation receiving oral anticoagulants (based on REGistry of long-term AnTithrombotic TherApy – REGATTA)
por: Ekaterina S. Kropacheva, et al.
Publicado: (2021)